Products Antibodies Monoclonal Antibodies Anti-NSDHL Monoclonal Antibody for WB, ELISA - Q15738
Anti-NSDHL Monoclonal Antibody for WB, ELISA - Q15738

Monoclonal Antibodies

Anti-NSDHL Monoclonal Antibody for WB, ELISA - Q15738

Item Number : CM0003200

Price varies based on specs and customizations


Application
WB, ELISA
Cross Reactivity
Human
Protein Weight
42kDa
ISO & CE icon

Shipping:

Contact us to get shipping details Enjoy On-time Dispatch Guarantee.

View Specs

Why Choose Us

Easy ordering process, quality products, and dedicated support for your business success.

Easy Process Quality Assured Dedicated Support

Core Product Specifications and Parameters

Parameter Value
Product Name NSDHL Rabbit mAb
Remarks/Alias H105E3; XAP104; SDR31E1; NSDHL
Species Human
GeneID 50814
Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 50-150 of human NSDHL (NP_057006.1)
Source Rabbit
Category Monoclonal Antibodies
Application WB, ELISA
Cross Reactivity Human
SWISS Q15738
Protein Weight 42kDa
Shipping Ice bag

Biological Background: NSDHL Function and Localization

  • NSDHL (sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating), also known as Protein H105e3, is a 41.9 kDa enzyme encoded by the NSDHL gene (GeneID: 50814) on the X chromosome.
  • It catalyzes the NAD(P)(+)-dependent oxidative decarboxylation of the C4 methyl groups of 4-alpha-carboxysterols, an essential step in post-squalene cholesterol biosynthesis.
  • Subcellularly, NSDHL localizes primarily to the endoplasmic reticulum membrane and lipid droplets, consistent with its role in sterol and lipid metabolism.
  • The enzyme is also reported to play a role in the regulation of endocytic trafficking of the epidermal growth factor receptor (EGFR).
  • NSDHL is a multi-pass membrane protein with a predicted transmembrane helix; it belongs to the sterol biosynthesis oxidoreductase family and requires NAD as a cofactor.
  • Expression of NSDHL is detected in multiple tissues, including brain, heart, liver, lung, kidney, skin, and placenta.
  • Mutations in NSDHL are associated with X-linked chondrodysplasia punctata 2 (CDPX2), a disorder characterized by ichthyosis and intellectual disability, highlighting its clinical relevance in human disease.

Experimental Guidance and Technical Tips

  • For western blotting, a band corresponding to NSDHL is expected at approximately 42 kDa; consider using total cell or tissue lysates from human sources known to express NSDHL (e.g., liver, skin).
  • The immunogen covers amino acids 50–150 of human NSDHL; verify that the epitope is accessible under denaturing and reducing conditions for WB.
  • For ELISA, use recombinant NSDHL protein or peptide as a standard to establish assay conditions; pairing with a detection antibody may require optimization.
  • As a rabbit monoclonal antibody, it typically offers high specificity and lot-to-lot consistency; however, each new application should be validated in the relevant sample system.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio provides diagnostic manufacturers and research laboratories with one-stop access to IVD raw materials, technical services, and consulting—from concept to clinic. This NSDHL antibody, targeting a key enzyme in cholesterol biosynthesis, is well-suited for research into metabolic disorders, skin barrier dysfunction, and EGFR trafficking. In addition to validated antibody pairs and bulk reagents, CamelBio supports rare target raw-material sourcing to accelerate your assay development and manufacturing needs.

View more faqs for this product

Product Datasheet

Anti-NSDHL Monoclonal Antibody for WB, ELISA - Q15738


REQUEST A QUOTE

Our professional team will reply to you within one business day. Please feel free to contact us!